Diagnosing the decline of major pharmaceutical research laboratories: A prescription for drug companies
- 1 March 1995
- journal article
- editorial
- Published by Wiley in Drug Development Research
- Vol. 34 (3), 243-259
- https://doi.org/10.1002/ddr.430340302
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Biopharmaceutical firms up R&D spending 89%Nature Biotechnology, 1994
- Resetting the model for long–term successBio/Technology, 1994
- Biotech alliances continue to evolveBio/Technology, 1994
- Pharmaceutical applications of biotechnology: Promise and reality. Editorial overviewCurrent Opinion in Biotechnology, 1993
- Surviving as a niche player in the pharmaceutical industry: Reflections from the fieldDrug Development Research, 1993
- Setting the record straight: The office of technology assessment report—pharmaceutical R&D costs, risks, and rewardsDrug Development Research, 1993
- Biotechnology in the drug discovery process: Strategic and management issuesMedicinal Research Reviews, 1993
- The dilemma of biotechnologyDrug Development Research, 1993
- Cost of innovation in the pharmaceutical industryJournal of Health Economics, 1991
- Patents and technology transferTrends in Biotechnology, 1990